CO2023002823A2 - Vacunas vivas liofilizadas de bordetella - Google Patents

Vacunas vivas liofilizadas de bordetella

Info

Publication number
CO2023002823A2
CO2023002823A2 CONC2023/0002823A CO2023002823A CO2023002823A2 CO 2023002823 A2 CO2023002823 A2 CO 2023002823A2 CO 2023002823 A CO2023002823 A CO 2023002823A CO 2023002823 A2 CO2023002823 A2 CO 2023002823A2
Authority
CO
Colombia
Prior art keywords
bordetella
freeze
bordetella bacteria
buffer
lyophilization
Prior art date
Application number
CONC2023/0002823A
Other languages
English (en)
Spanish (es)
Inventor
Marcel Thalen
Original Assignee
Iliad Biotechnologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iliad Biotechnologies Llc filed Critical Iliad Biotechnologies Llc
Publication of CO2023002823A2 publication Critical patent/CO2023002823A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CONC2023/0002823A 2020-08-14 2023-03-07 Vacunas vivas liofilizadas de bordetella CO2023002823A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063066020P 2020-08-14 2020-08-14
PCT/US2021/046055 WO2022036298A1 (en) 2020-08-14 2021-08-15 Lyophilized live bordetella vaccines

Publications (1)

Publication Number Publication Date
CO2023002823A2 true CO2023002823A2 (es) 2023-03-27

Family

ID=80247370

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0002823A CO2023002823A2 (es) 2020-08-14 2023-03-07 Vacunas vivas liofilizadas de bordetella

Country Status (12)

Country Link
US (1) US20230173053A1 (enExample)
EP (1) EP4196155A4 (enExample)
JP (1) JP7809362B2 (enExample)
KR (1) KR20230051186A (enExample)
CN (1) CN116322756A (enExample)
AU (1) AU2021325149A1 (enExample)
BR (1) BR112023002549A2 (enExample)
CA (1) CA3187934A1 (enExample)
CL (1) CL2023000451A1 (enExample)
CO (1) CO2023002823A2 (enExample)
MX (1) MX2023001905A (enExample)
WO (1) WO2022036298A1 (enExample)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2215033C2 (ru) * 2001-06-27 2003-10-27 Научно-исследовательский институт микробиологии МО РФ Способ получения концентрата микробных клеток в производстве чумных вакцин
EP1708747A2 (en) * 2004-01-15 2006-10-11 Intervet International BV Non-animal origin stabilizers and processes for producing the same
US9119804B2 (en) 2006-03-10 2015-09-01 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
AR097762A1 (es) * 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
EP4541809A3 (en) 2016-03-29 2025-06-25 Institut Pasteur de Lille Mutant bordetella strains and methods of use
RU2709657C2 (ru) * 2017-08-07 2019-12-19 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) Способ лиофильного высушивания аттенуированных бактерий B. pertussis, аттенуированная бактерия B. pertussis, штамм аттенуированных бактерий B. Pertussis, вакцина, лиофилизированный вакцинный препарат
WO2020049133A1 (en) 2018-09-05 2020-03-12 National University Of Singapore Adenylate cyclase catalytic domain deficient bordetella strains

Also Published As

Publication number Publication date
US20230173053A1 (en) 2023-06-08
CA3187934A1 (en) 2022-02-17
JP7809362B2 (ja) 2026-02-02
WO2022036298A1 (en) 2022-02-17
JP2023540453A (ja) 2023-09-25
AU2021325149A1 (en) 2023-03-02
CN116322756A (zh) 2023-06-23
CL2023000451A1 (es) 2023-10-20
EP4196155A1 (en) 2023-06-21
KR20230051186A (ko) 2023-04-17
MX2023001905A (es) 2023-03-13
EP4196155A4 (en) 2025-03-19
BR112023002549A2 (pt) 2023-03-07

Similar Documents

Publication Publication Date Title
CN108102982A (zh) 麦氏弧菌的真空冷冻干燥保护剂及其保藏方法
CO2023002823A2 (es) Vacunas vivas liofilizadas de bordetella
CN104212733A (zh) 一种光合细菌冻干保护剂
RU2487542C2 (ru) Энтомопатогенный биопрепарат для защиты растений от вредителей и способ его получения
Lopes et al. Liquid Bacillus subtilis formulation in rice for the control of Meloidogyne javanica and lettuce improvement
CN103451099B (zh) 假交替单胞菌属细菌的冻干保护剂及冻干方法
CN102199560A (zh) 鸡白痢沙门氏菌减毒突变株△S6702(RfaG)及其构建方法
Souza et al. Biopolymers in the preservation of rhizobacteria cells and efficiency in soybean inoculation
Emmons et al. Isolation of Histoplasma capsulatum from fresh and deep-frozen peribronchial lymph nodes of dogs by mouse inoculation
RU2292388C1 (ru) Способ сохранения жизнеспособности штамма патогенных бледных трепонем
ES2362035B2 (es) Cepa bacteriana cect7624, usos y producto xeroprotector producido por la misma.
CN105462840A (zh) 一种口腔支原体的活体冻干体的制备方法
RU2301078C1 (ru) Вакцина ассоциированная против колибактериоза, сальмонеллеза и энтерококковой инфекции нутрий
CN103301453A (zh) 一种猪繁殖与呼吸综合征冻干疫苗及其制备方法
CN102380093A (zh) 一种利用传代成纤维细胞生产鸡新城疫活疫苗的方法
CN103981151B (zh) 一种伪狂犬灭活疫苗及其制备方法
MD1379Z (ro) Procedeu de conservare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20
RU1589448C (ru) Защитная среда для лиофилизации вакцинного штамма erysipelothrix rhusiopathicae suis bp-2
CN113322198B (zh) 一种基于氧化胺黄色杆菌和稻黄杆菌的微生物菌剂及其制备方法与应用
CN109957509A (zh) 一种罗非鱼源无乳链球菌弱毒株冻干保存及复苏技术
Berman et al. Freeze-drying various attenuated strains of Pasteurella pestis
MD1380Z (ro) Procedeu de conservare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20
CN118562747A (zh) 一种伪狂犬病病毒湿毒保存方法、用途
RU2421512C1 (ru) Питательная среда для культивирования энтомопатогенных грибов
RU2015131897A (ru) Способ получения стерильной лиофилизированной добавки из личинок и куколок трутней